Author Archives: Melanie

DEA Makes Reclassification Announcement

Drug Enforcement Administration (DEA) has announced that by October 6, 2014, all hydrocodone combination medications will be reclassified from Schedule III to Schedule II. This action, prompted by a recommendation from the Food and Drug Administration, is aimed at reducing … Continue reading